HPV-Vaccines / / edited by Gloria Calagna.
Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophyl...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | [Place of publication not identified] : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023. |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (214 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 01847nam a2200289 i 4500 | ||
---|---|---|---|
001 | 993610551304498 | ||
005 | 20230816114832.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 230816s2023 xx o 000 0 eng d | ||
035 | |a (CKB)5470000002907834 | ||
035 | |a (NjHacI)995470000002907834 | ||
035 | |a (EXLCZ)995470000002907834 | ||
040 | |a NjHacI |b eng |e rda |c NjHacl | ||
050 | 4 | |a QR406 |b .H688 2023 | |
082 | 0 | 4 | |a 576.6484 |2 23 |
245 | 0 | 0 | |a HPV-Vaccines / |c edited by Gloria Calagna. |
264 | 1 | |a [Place of publication not identified] : |b MDPI - Multidisciplinary Digital Publishing Institute, |c 2023. | |
300 | |a 1 online resource (214 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
588 | |a Description based on publisher supplied metadata and other sources. | ||
520 | |a Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines-quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine-are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers. | ||
650 | 0 | |a Vaccines. | |
650 | 0 | |a Papillomaviruses. | |
776 | |z 3-0365-5918-3 | ||
700 | 1 | |a Calagna, Gloria, |e editor. | |
906 | |a BOOK | ||
ADM | |b 2023-08-18 03:30:30 Europe/Vienna |f system |c marc21 |a 2023-07-04 13:45:39 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5346844360004498&Force_direct=true |Z 5346844360004498 |b Available |8 5346844360004498 |